Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Setmelanotide Acetate in Bardet-Biedl Syndrome: NCT07674290 Clinical Landscape Report 2026
16 October 2026
NCT07674290 clinical landscape for Bardet-Biedl Syndrome: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Efsubaglutide Alfa in Pediatric Obesity: NCT07693426 Clinical Landscape Report 2026
16 October 2026
NCT07693426 clinical landscape for Pediatric Obesity: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Acetyl-L-carnitine in Diabetes Mellitus, Type 2: NCT07660081 Clinical Landscape Report 2026
16 October 2026
NCT07660081 clinical landscape for Diabetes Mellitus, Type 2: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
GLP-1 agonist (Nxera Pharma) in Infertility, Female: NCT07687667 Clinical Landscape Report 2026
16 October 2026
NCT07687667 clinical landscape for Infertility, Female: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Zovaglutide in Obesity: NCT07697846 Clinical Landscape Report 2026
16 October 2026
NCT07697846 clinical landscape for Obesity: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Finerenone in Obesity, Abdominal: NCT07678151 Clinical Landscape Report 2026
16 October 2026
NCT07678151 clinical landscape for Obesity, Abdominal: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Propofol in Obesity: NCT07665645 Clinical Landscape Report 2026
16 October 2026
NCT07665645 clinical landscape for Obesity: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Lumateperone Tosylate in Bipolar Disorder: NCT07699445 Clinical Landscape Report 2026
16 October 2026
NCT07699445 clinical landscape for Bipolar Disorder: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
MuSK CAART in Myasthenia Gravis: NCT05451212 Clinical Landscape Report 2026
15 October 2026
NCT05451212 clinical landscape for Myasthenia Gravis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
BBM-H803 in Hemophilia A: NCT05454774 Clinical Landscape Report 2026
15 October 2026
NCT05454774 clinical landscape for Hemophilia A: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Ristoglogene Autogetemcel in Vaso-occlusive crisis: NCT05456880 Clinical Landscape Report 2026
15 October 2026
NCT05456880 clinical landscape for Vaso-occlusive crisis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Dapagliflozin in Diabetes Mellitus, Type 2: NCT05459701 Clinical Landscape Report 2026
15 October 2026
NCT05459701 clinical landscape for Diabetes Mellitus, Type 2: endpoints, sponsor, phase, geography, readouts, asset context and development white space.